Navigation Links
Kenya halts first field trials of GM maize

Kenyan authorities began destroying the country's first genetically modified (GM) maize growing in open field trials.

The government halted the research and ordered the destruction after discovering that a technician had sprayed a restricted pesticide on maize modified to resist attack by insects called stem borers.

Wilson Songa, Kenya's agriculture secretary and chair of the National Biosafety Committee, said this could compromise the validity of the trial's results.

On 25 August, the committee ordered the Kenya Plant Health Inspectorate Service to destroy the crops.

Songa was quoted in Kenya's Sunday Nation newspaper on 28 August as saying that local scientists had yielded to pressure from international organisations and were "rushing projects".

The maize was being grown in Kiboko by the Insect Resistance Maize for Africa (IRMA) project, a joint initiative of the Kenyan Agricultural Research Institute, the US-based Syngenta foundation, and the Mexico-based Center for Maize and Wheat Research.

In July, IRMA staff had notified the biosafety committee that the maize had been sprayed with the insecticide Furadan.

Stephen Mugo, IRMA's project coordinator, says the incident was unfortunate and a major setback to Kenyan research, but that GM maize field trials would continue.

"This is just like a battle we lost," said Mugo. "But the main war will continue until we help African maize farmers overcome the pest".

Stem borers destroy up to 12 per cent of maize growing in Kenya, amounting to US$76 million in lost harvests per year.

The IRMA project, which began six years ago, aims to develop both conventional and GM maize varieties to resist the pest.

The GM plants, which incorporate genetic material from a bacterium called Bacillus thuringiensis, have already been grown under experimental conditions in IRMA's US$12 million 'biosafety' greenhouse (see $12 million greenhouse signals Kenyan GM commitment).

When the first IRMA maize seeds were sown outside in May, Kenya became the first African country after South Africa to plant GM maize in open fields (see Kenya begins first open field trials of GM maize).
The IRMA researchers had hoped to release the maize to farmers by 2010 (see Revision of plans delays Kenya's GM maize).


'"/>

Source:SciDev.Net


Related biology news :

1. Intrinsic eye protein halts angiogenesis
2. Trojan Horse agent halts bone metastasis in mice
3. A genes first kiss sets off that affair known as puberty
4. Love at first smell
5. Worlds largest rainforest drying experiment completes first phase
6. PCRM develops worlds first cruelty-free insulin assay
7. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
8. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
9. DuPonts first biologically derived polymer receives global recognition
10. Anti cancer virotherapy well tolerated in first human administration, research finds
11. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology: